How is the Wells score calculated to estimate the pre‑test probability of pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Wells Score Calculation for Pulmonary Embolism

The Wells score is calculated by assigning points to seven clinical variables, with a total possible score ranging from 0 to 12.5 points, which can then be interpreted using either a three-tier system (low ≤1, moderate 2-6, high ≥7) or a simplified two-tier dichotomization (PE-unlikely ≤4, PE-likely >4). 1

Wells Score Components and Point Values

The Wells prediction rule assigns points as follows:

  • Clinical signs/symptoms of DVT: 3 points
  • PE is the #1 diagnosis OR equally likely: 3 points
  • Heart rate >100 bpm: 1.5 points
  • Immobilization ≥3 days OR surgery in previous 4 weeks: 1.5 points
  • Previous PE or DVT: 1.5 points
  • Hemoptysis: 1 point
  • Malignancy (treatment within 6 months or palliative): 1 point

1

Score Interpretation Systems

Three-Tier Classification

  • Low probability: Score ≤1 (PE prevalence ~2%)
  • Moderate probability: Score 2-6 (PE prevalence ~15%)
  • High probability: Score ≥7 (PE prevalence ~43%)

2

Two-Tier Dichotomization (Simplified Wells)

  • PE-unlikely: Score ≤4 (PE prevalence ~3%)
  • PE-likely: Score >4 (PE prevalence ~28%)

2

Clinical Application Algorithm

The simplified two-tier Wells score (dichotomized at ≤4 vs >4) demonstrates comparable diagnostic performance to the three-tier system while being easier to implement in clinical practice. 3 The dichotomized version shows substantial interrater agreement (kappa 0.72) compared to moderate agreement for the three-tier system (kappa 0.54). 2

Integration with D-dimer Testing

  • Wells ≤4 (PE-unlikely): Proceed to D-dimer testing. If D-dimer is normal (age-adjusted: age × 10 ng/mL for patients >50 years, or <500 ng/mL), PE is excluded without imaging. 1

  • Wells >4 (PE-likely): Proceed directly to imaging (CTPA) without D-dimer testing, as a negative D-dimer will not obviate the need for imaging. 1

Important Clinical Caveats

A critical pitfall is misunderstanding that each epidemiologic risk factor does not independently contribute to the Wells score—only the specific seven variables listed above are scored. 1 The "PE is #1 diagnosis" criterion requires clinical judgment and contributes significantly (3 points), making this somewhat subjective despite the otherwise objective criteria.

The Wells score has been externally validated and performs similarly to clinician gestalt and the Geneva score, with no clear superiority among these tools. 1 However, the structured approach of the Wells score provides standardization particularly valuable for clinicians who infrequently evaluate PE. 1

When combined with age-adjusted D-dimer cutoffs, the simplified Wells rule maintains sensitivity >97% while improving specificity, making it the preferred approach for ruling out PE in low-to-moderate risk patients. 3

References

Related Questions

How is the Modified Wells Score calculated and interpreted for assessing pre‑test probability of pulmonary embolism?
What is the Geneva score and how is it used to assess the probability of pulmonary embolism?
Can D-dimer and the Wells score be used to confidently exclude pulmonary embolism and avoid CT pulmonary angiography (CTPA)?
How should I evaluate and manage a patient with a blood pressure of 122/77 mm Hg and a heart rate of 123 beats per minute (tachycardia)?
Should a 13-year-old patient requesting breast augmentation undergo the procedure, and what is the appropriate management if it should not be performed?
How should a patient with hepatitis B, chronic obstructive pulmonary disease, and pancreatitis be treated?
For a 5‑year‑old child who has received four doses of diphtheria‑tetanus‑acellular pertussis (DTaP) vaccine and three doses of inactivated poliovirus (IPV) vaccine, which vaccines are indicated now and can the child receive the combination vaccine Kinrix (DTaP‑IPV) as his fifth DTaP and fourth IPV dose?
When should pulmonary embolism be suspected and what constitutes a not‑high pre‑test probability?
What is the appropriate management for an 18-year-old patient who presents with left‑ear cerumen impaction causing a sensation of blockage and right‑ear excess cerumen, without pain, fever, or signs of infection?
What are the recommended dosing regimens for Vraylar (cariprazine) for schizophrenia, bipolar I manic episodes, bipolar I depressive episodes, and major depressive disorder, including dose adjustments for elderly patients and hepatic impairment?
For a patient with chronic obstructive pulmonary disease who is at risk for renal impairment and osteoporosis, should tenofovir alafenamide (TAF) be preferred over tenofovir disoproxil fumarate (TDF) for hepatitis B therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.